Progress in Neuro-Psychopharmacology & Biological Psychiatry

Papers
(The H4-Index of Progress in Neuro-Psychopharmacology & Biological Psychiatry is 36. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-12-01 to 2025-12-01.)
ArticleCitations
Editorial Board101
Synergistic effect of folate and MTHFR C677T on hippocampal subfields and perfusion in Alzheimer's disease89
Causal relationship between genetically determined plasma metabolites and stroke: A two sample Mendelian randomization study89
N-acetyl cysteine (NAC) augmentation in the treatment of obsessive-compulsive disorder: A phase III, 20-week, double-blind, randomized, placebo-controlled trial88
Small molecule NOP agonists reverse locomotor sensitization induced by cocaine in male C57BL/6 mice81
Neuroimaging-based subtypes of major depressive disorder in different sex and age groups: a potential link to sex hormone dynamics81
Sex-specific association between schizophrenia polygenic risk and subclinical schizophrenia-related traits80
Anomalous neurovascular coupling in patients with generalized anxiety disorder evaluated by combining cerebral blood flow and functional connectivity strength79
Bed nucleus of the stria terminalis CB1 receptors and the FAAH enzyme modulate anxiety behavior depending on previous stress exposure74
Dopamine D3 receptor in the nucleus accumbens modulates opioid taking and seeking in mice73
Genetic variation of the estrogen receptor and its association with depression and anxiety symptoms in young females68
Identifying novel protein biomarkers with cross-psychiatric disorders effects and potential intervention targets: Evidence from proteomic-Mendelian randomization63
Association evaluations of oral anticoagulants with dementia risk based on genomic and real-world data60
Editorial Board59
Evidence on sociodemographic and clinical correlates of antidepressant combination or augmentation with second-generation antipsychotics in major depressive disorder56
Adenosine A2A receptor modulation affects the development of depressive-like behaviour and dopamine D2 receptor availability in rats exposed to repeated social defeat56
Early auditory impairments as a candidate marker of attenuated sensory symptoms of psychosis54
Assessment of cognitive domains in major depressive disorders using the Cambridge Neuropsychological Test Automated Battery (CANTAB): Systematic review and meta-analysis of cross-sectional and longitu51
Exploring the causal relationship between delirium and sarcopenia using bidirectional two-sample Mendelian randomization study48
The mechanistic basis for the rapid antidepressant-like effects of ketamine: From neural circuits to molecular pathways47
Polygenic predisposition to transdiagnostic symptom dimensions and treatment outcomes across psychiatric disorders46
Novel role of peroxisome proliferator activated receptor-α in valproic acid rat model of autism: Mechanistic study of risperidone and metformin monotherapy versus combination46
Sex differences in behavioral and neural responses induced by witnessing social defeat stress during adolescence or adulthood in mice44
Common neural correlates of chronic pain – A systematic review and meta-analysis of resting-state fMRI studies44
DNA methylation of serotonin genes as predictive biomarkers of antidepressant treatment response44
Cerebral blood flow in schizophrenia: A systematic review and meta-analysis of MRI-based studies44
Effect of depression and suicidal behavior on neuropeptide Y (NPY) and its receptors in the adult human brain: A postmortem study43
Melatonin ameliorates methamphetamine-induced cognitive impairments by inhibiting neuroinflammation via suppression of the TLR4/MyD88/NFκB signaling pathway in the mouse hippocampus42
Neochlorogenic acid ameliorates Alzheimer's disease-like pathology via scavenging oxidative stress and restoring blood-brain barrier function in zebrafish41
Long-term benzodiazepine prescription in treatment-resistant depression: A national FACE-TRD prospective study40
Impairment of olfactory identification ability in ultra-high risk for psychosis and drug-naïve first episode psychosis39
Editorial Board39
Combined cognitive assessment and automated MRI volumetry improves the diagnostic accuracy of detecting MCI due to Alzheimer's disease39
Putative epicenters identified by transcriptome-neuromorphic interactions in attention-deficit/hyperactivity disorder biotypes38
Neurogliovascular unit adaptations following chronic distress predict motivational deficits in mice38
Neural basis of the association between future time perspective and ADHD characteristics: functional connectivity between Left inferior parietal lobule and mPFC37
0.035629987716675